We are delighted to share the news that our custom lyo bead Development and Manufacturing service has been shortlisted for the 2023 Bionow awards in the category of Technical Service of the Year. Now in their 22nd year, the regional Bionow awards celebrate the innovation and impact of the Life Sciences sector. A panel of judges reviewed detailed case studies
2023 has been a year of incredible growth for our business Over the last twelve months, we have continued to develop long-term partnerships with some of the most innovative and influential companies within the diagnostics, food safety, DNA testing and personal health sectors. Fostering a culture of transparency and trust allows us to get closer to you, our customers, and
We’re pleased to announce that we have started the installation of solar power panels here at Biofortuna. With solar power we can reduce our reliance on the National Grid in favour of using renewable energy, reduce our carbon footprint significantly, and do our bit to tackle global warming. Why have we chosen to install solar power? Clean
We are proud to support the UICC’s World Cancer Day initiative
Biofortuna (Deeside UK), a specialist contract development and manufacturing partner to the IVD and point of care testing sectors, has more than doubled its manufacturing capacity following its relocation to new state-of-the-art facilities in Deeside, North Wales. The purpose-built facilities have been designed by the Company to provide the most efficient and modern manufacturing laboratories from which to meet
We are delighted to share the news that we have been shortlisted for the 2020 BioNow awards.
Biofortuna sees record production levels across November and December
Biofortuna has provided assay development and manufacturing support to QuantuMDx Group Limited to assist in the manufacturing scale-up, regulatory approval and launch of their rapid, sensitive SARS-CoV-2 test.
In light of the current situation with COVID-19, we would like to take this opportunity to assure you that plans have been put into place to ensure business continuity at Biofortuna.
Biofortuna (Liverpool, UK) – the international IVD contract research and contract manufacturing company – will be launching ampDRY™, its patent pending stabilised master mix for PCR applications, at the AACC Annual Scientific Meeting and Clinical Lab Expo in Chicago, July 29 to August 2. ampDRY hotstart master mix has been developed to enable complete end-stage or real-time PCR assays to